Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
23.03
+0.67 (+3.00%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
June 08, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Organon and CAF, Development Bank of Latin America, Launch First-of-Its-Kind Collaboration to Increase Sustainable Financing in Women’s Health
June 07, 2023
From
Organon & Co.
Via
Business Wire
7 Stocks That Are Long Overdue for a Relief Rally
May 18, 2023
Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment.
Via
InvestorPlace
Daily Stock Analysis: Organon & Co
May 15, 2023
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions.
Via
Talk Markets
Organon's Return On Capital Employed Insights
May 15, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 15, 2023
Via
Benzinga
Organon's Earnings: A Preview
May 03, 2023
Via
Benzinga
Organon: Dividend Insights
February 21, 2023
Via
Benzinga
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
May 09, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Organon Reports Results for the First Quarter Ended March 31, 2023
May 04, 2023
From
Organon & Co.
Via
Business Wire
Organon To Report First Quarter and Host Conference Call on May 4, 2023
April 20, 2023
From
Organon & Co.
Via
Business Wire
7 Growth Stocks That Are Trading at a Bargain Price
April 02, 2023
Some analysts suggest that equities are in the beginning of a bull market. If so, now is a good time to look at buying bargain growth stocks.
Via
InvestorPlace
Why Shares of Organon Fell 15% Thursday
February 16, 2023
The company reported fourth-quarter and year-end financials.
Via
The Motley Fool
Earnings Scheduled For February 16, 2023
February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...
Via
Benzinga
Earnings Preview For Organon
February 15, 2023
Via
Benzinga
5 Value Stocks In The Healthcare Sector
March 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
March 16, 2023
Via
Benzinga
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
March 07, 2023
From
Organon & Co.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 16, 2023
Via
Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 16, 2023
Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
Via
Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
February 16, 2023
From
Organon
Via
Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
February 06, 2023
From
Organon & Co.
Via
Business Wire
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
January 31, 2023
Amgen launched its biosimilar knockoff on Tuesday at a steep discount.
Via
Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
January 26, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy.
Via
Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
January 17, 2023
Organon sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
January 05, 2023
From
Organon & Co.
Via
Business Wire
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
December 15, 2022
From
Organon & Co.
Via
Business Wire
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
December 12, 2022
From
Organon & Co.
Via
Business Wire
3 Dow Stocks to Take Seriously in 2023
November 29, 2022
The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.